The Motley Fool

Why I’d still shun Carillion plc shares at less than 20p

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Embattled construction services group Carillion (LSE: CLLN) has been sliding ever deeper into financial trouble. And a story from Sky News at the weekend claimed it’s now “racing to secure new funding within weeks to avoid collapse.”

A spokesman said it’s finalising a business plan to present to its syndicate of lenders on Wednesday. The company made no official statement to the stock market this morning but its shares are up 17% to 22p, as I’m writing. This values it at £95m, but the trouble is, total debt is £1.5bn.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

1p a share target

Sky reported that Carillion has come up with a rescue plan, which “would involve handing back some lossmaking contracts, revising the terms of others and potentially accepting financial support from the Government if it cannot secure it from private sector sources.”

This may account for the rise in the share price today. However, institutional shareholders have deserted the company in droves and I believe the price is now being driven by short-term traders and naive retail investors. They could think they see a wide margin of safety in the company’s P/E of one, but fail to appreciate the gravity and implications of its financial position.

Back in October, when the shares were trading at 47p, I drew readers’ attention to a note from analysts at UBS, who saw “no material equity value left for current shareholders” and put a 1p target on the shares. At that time, I thought this was an extreme, but far from negligible, outcome and rated the stock a ‘sell’. Subsequent events (including news of an FCA investigation into announcements made by the company last year) have persuaded me it’s a probable outcome.

In the kind of situation of extreme distress in which Carillion finds itself, a financial restructuring almost invariably involves a hugely dilutive debt-for-equity swap and fundraising and leaves existing shareholders with a token few million of equity. In Carillion’s case, this would equate to around the 1p a share of UBS’s target. As such, I rate the stock a ‘sell’ at the current price — indeed, at almost any price.

A credible turnaround stock?

Short-sellers, who went through Carillion’s accounts with a fine toothcomb a few years ago, concluded that the company’s accounting was aggressive and that its many acquisitions obscured a multitude of sins. They reckoned these issues also tainted other companies in the sector, including Capita (LSE: CPI).

Like Carillion, Capita has had to book multi-million pound impairments. However, Capita’s haven’t been as extreme and, unlike its troubled peer, it’s been able to bolster its balance sheet with an £888m sale of one of its businesses. While the company has said it expects to record further impairments in its results for the year ended 31 December, it has also said it expects year-end net debt/EBITDA to be around 2.25. This is a reasonable level and down from 2.9 at 30 June.

At a current share price of 410p, Capita trades on a P/E of 8.5. I see risk here as still elevated but infinitely lower than at Carillion. On the basis of debt being under control, the low earnings multiple and credible turnaround prospects, I rate Capita a ‘buy’.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.